JP2019501937A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501937A5
JP2019501937A5 JP2018536436A JP2018536436A JP2019501937A5 JP 2019501937 A5 JP2019501937 A5 JP 2019501937A5 JP 2018536436 A JP2018536436 A JP 2018536436A JP 2018536436 A JP2018536436 A JP 2018536436A JP 2019501937 A5 JP2019501937 A5 JP 2019501937A5
Authority
JP
Japan
Prior art keywords
diazaspiro
phenyl
dimethylamino
decane
sith
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536436A
Other languages
English (en)
Japanese (ja)
Other versions
JP6893516B2 (ja
JP2019501937A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/025005 external-priority patent/WO2017121647A1/en
Publication of JP2019501937A publication Critical patent/JP2019501937A/ja
Publication of JP2019501937A5 publication Critical patent/JP2019501937A5/ja
Application granted granted Critical
Publication of JP6893516B2 publication Critical patent/JP6893516B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536436A 2016-01-13 2017-01-13 3−((ヘテロ−)アリール)−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体 Active JP6893516B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16151012 2016-01-13
EP16151012.8 2016-01-13
PCT/EP2017/025005 WO2017121647A1 (en) 2016-01-13 2017-01-13 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021032291A Division JP7148660B2 (ja) 2016-01-13 2021-03-02 3-((ヘテロ-)アリール)-8-アミノ-2-オキソ-1,3-ジアザ-スピロ-[4.5]-デカン誘導体

Publications (3)

Publication Number Publication Date
JP2019501937A JP2019501937A (ja) 2019-01-24
JP2019501937A5 true JP2019501937A5 (enExample) 2021-04-15
JP6893516B2 JP6893516B2 (ja) 2021-06-23

Family

ID=55129633

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018536436A Active JP6893516B2 (ja) 2016-01-13 2017-01-13 3−((ヘテロ−)アリール)−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体
JP2021032291A Active JP7148660B2 (ja) 2016-01-13 2021-03-02 3-((ヘテロ-)アリール)-8-アミノ-2-オキソ-1,3-ジアザ-スピロ-[4.5]-デカン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021032291A Active JP7148660B2 (ja) 2016-01-13 2021-03-02 3-((ヘテロ-)アリール)-8-アミノ-2-オキソ-1,3-ジアザ-スピロ-[4.5]-デカン誘導体

Country Status (30)

Country Link
US (7) US20170197970A1 (enExample)
EP (2) EP3402781B1 (enExample)
JP (2) JP6893516B2 (enExample)
KR (2) KR102768715B1 (enExample)
CN (2) CN114149413A (enExample)
AR (2) AR107434A1 (enExample)
AU (1) AU2017206908B2 (enExample)
BR (1) BR112018014305B1 (enExample)
CA (1) CA3011176C (enExample)
CL (1) CL2018001911A1 (enExample)
CO (1) CO2018008447A2 (enExample)
CY (1) CY1122923T1 (enExample)
DK (2) DK3402781T5 (enExample)
EA (2) EA037598B1 (enExample)
EC (1) ECSP18060834A (enExample)
ES (2) ES2807549T3 (enExample)
FI (1) FI3722284T3 (enExample)
HR (2) HRP20250176T1 (enExample)
HU (2) HUE049771T2 (enExample)
IL (2) IL260496B (enExample)
LT (2) LT3402781T (enExample)
MX (1) MX378607B (enExample)
PE (2) PE20181646A1 (enExample)
PL (2) PL3722284T3 (enExample)
PT (2) PT3402781T (enExample)
RS (2) RS60307B1 (enExample)
SI (2) SI3722284T1 (enExample)
TW (1) TWI635082B (enExample)
WO (1) WO2017121647A1 (enExample)
ZA (1) ZA201805356B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6893517B2 (ja) 2016-01-13 2021-06-23 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 3−((ヘテロ−)アリール)−アルキル−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体
TWI635082B (zh) 2016-01-13 2018-09-11 歌林達有限公司 3-((雜-)芳基)-8-胺基-2-側氧-1,3-二氮雜-螺-[4.5]-癸烷衍生物
MX378995B (es) 2016-01-13 2025-03-11 Gruenenthal Gmbh Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
RS60855B1 (sr) 2016-01-13 2020-10-30 Gruenenthal Gmbh Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
US10961242B2 (en) * 2017-05-17 2021-03-30 Legochem Biosciences, Inc. Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same
WO2020144375A1 (en) 2019-01-11 2020-07-16 Grünenthal GmbH Substituted pyrrolidine amides iii
CN110862395B (zh) * 2019-11-13 2020-09-29 株洲千金药业股份有限公司 一种制备他达拉非重要杂质的原料化合物的制备方法
US20240400537A1 (en) * 2023-04-25 2024-12-05 Gruenenthal Gmbh Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734265B1 (fr) 1995-05-17 1997-06-13 Adir Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
RU2268883C2 (ru) 2001-04-18 2006-01-27 Эро-Селтик, С.А. Аналоги ноницептина и фармацевтическая композиция на их основе
DE10130020A1 (de) 2001-06-25 2003-12-04 Gruenenthal Gmbh Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
PT1519939E (pt) 2002-07-05 2010-02-10 Targacept Inc Compostos n-arildiazaspirocíclicos e métodos para a sua preparação e utilização
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
ZA200510329B (en) 2003-05-23 2007-04-25 Zealand Pharma As Triaza-spiro compounds as nociceptin analogues and uses thereof
JO2676B1 (en) 2004-04-06 2012-06-17 جانسين فارماسوتيكا ان. في Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines
DE102005023784A1 (de) 2005-05-19 2006-11-30 Grünenthal GmbH Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
DE102005044813A1 (de) 2005-05-19 2007-10-04 Grünenthal GmbH Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
DE102005030051A1 (de) 2005-06-27 2006-12-28 Grünenthal GmbH Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
DE102006019597A1 (de) 2006-04-27 2007-10-31 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
AU2007312391B2 (en) 2006-10-19 2012-06-21 F. Hoffmann-La Roche Ag Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
JP2010517964A (ja) * 2007-02-01 2010-05-27 グラクソ グループ リミテッド GlyT1トランスポーター阻害薬および神経学的および神経精神病学的障害の治療におけるその使用
EP2150552B1 (en) 2007-04-09 2013-01-02 Janssen Pharmaceutica NV 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
KR20120075500A (ko) * 2008-03-27 2012-07-06 그뤼넨탈 게엠베하 치환된 4-아미노사이클로헥산 유도체
TW201038572A (en) 2009-03-25 2010-11-01 Gruenenthal Gmbh Substituted spiro-amide compounds
US8268853B2 (en) 2009-06-25 2012-09-18 Abbott Laboratories 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
TWI582092B (zh) 2010-07-28 2017-05-11 歌林達股份有限公司 順式-四氫-螺旋(環己烷-1,1’-吡啶[3,4-b]吲哚)-4-胺-衍生物
EP3154971A4 (en) 2014-06-13 2017-11-01 Purdue Pharma L.P. Heterocyclic morphinan derivatives and use thereof
MX378995B (es) 2016-01-13 2025-03-11 Gruenenthal Gmbh Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
JP6893517B2 (ja) 2016-01-13 2021-06-23 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 3−((ヘテロ−)アリール)−アルキル−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体
DK3402783T3 (da) 2016-01-13 2020-05-04 Gruenenthal Gmbh 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater
TWI730032B (zh) 2016-01-13 2021-06-11 美商必治妥美雅史谷比公司 作為rock抑制劑之螺庚烷水楊酸醯胺及相關化合物
RS60855B1 (sr) 2016-01-13 2020-10-30 Gruenenthal Gmbh Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
TWI635082B (zh) 2016-01-13 2018-09-11 歌林達有限公司 3-((雜-)芳基)-8-胺基-2-側氧-1,3-二氮雜-螺-[4.5]-癸烷衍生物
RU2747877C2 (ru) 2016-01-13 2021-05-17 Ново Нордиск А/С Аналоги эфр(а) с заместителями - жирными кислотами

Similar Documents

Publication Publication Date Title
HRP20250176T1 (hr) Derivati 3-((hetero-)aril)-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
US20250223278A1 (en) Pyridazinone compounds and uses thereof
US20190345138A1 (en) Heterocyclic amides as kinase inhibitors
CA2624602A1 (en) Process for preparing 6-substituted-7-azaindoles
JP2014531465A5 (enExample)
JP2004504301A5 (enExample)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
US10376510B2 (en) 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
RU2015113746A (ru) Замещенные сульфонамиды
JP2023506642A5 (enExample)
JP2020536116A5 (enExample)
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
JP2016523976A5 (enExample)
HRP20171454T1 (hr) Fuzionirani heterociklični spojevi kao modulatori ionskih kanala
JP2014523400A5 (enExample)
JP2018508553A5 (enExample)
TW201429957A (zh) 用於激酶調節及其適應症之化合物及方法
JP2017511329A5 (enExample)
JP2016522246A5 (enExample)
JP2004534826A5 (enExample)
RU2009148304A (ru) Модуляторы гидролазы амидов жирных кислот на основе гетероарилзамещенной мочевины
JP2019501939A5 (enExample)
RU2013132930A (ru) Производное пиразола
HRP20200837T1 (hr) Derivati 3-((hetero-)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
RU2017120859A (ru) Замещенные мостиковые аналоги мочевины в качестве модуляторов сиртуина